Breast Cancer Risk Assessment and Risk Reduction

Gail, 1989, Projecting individualized probability of developing breast cancer for white females who are being examined annually, J Natl Cancer Inst, 81, 1879, 10.1093/jnci/81.24.1879 Rockhill, 2001, Validation of the Gail et al. Model of breast cancer risk prediction and implications of chemoprevention, J Natl Cancer Inst, 93, 358, 10.1093/jnci/93.5.358 Fabian, 2000, Short term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model, J Natl Cancer Inst, 92, 1217, 10.1093/jnci/92.15.1217 Fabian, 2000, Benign breast tissue sampling for prevention studies, Breast J, 6, 215, 10.1046/j.1524-4741.2000.20024.x Dooley, 2001, Ductal lavage for detection of cellular atypia in women at high risk for breast cancer, J Natl Cancer Inst, 93, 1624, 10.1093/jnci/93.21.1624 Boyd, 1999, Mammographic densities and risk of breast cancer among subjects with a family history of the disease, J Natl cancer Inst, 91, 1404, 10.1093/jnci/91.16.1404 Boyd, 2005, Mammographic density as an intermediate phenotype for breast cancer, Lancet Oncol, 6, 798, 10.1016/S1470-2045(05)70390-9 Key, 2002, Endogenous sex hormones and breast cancer in post menopausal women: reanalysis of nine prospective studies, J Natl Cancer Inst, 94, 606, 10.1093/jnci/94.8.606 Cauley, 1999, Elevated serum estradiol and testosterone concentrations are associated with high risk for breast cancer. Study of Osteoporotic Fractures Ressearch Group, Ann Intern Med, 130, 270, 10.7326/0003-4819-130-4_Part_1-199902160-00004 Meijers-Heijboer, 2001, Breast cancer after prophylactic mastectomy in women with a BRCA1 and BRCA2 mutation, N Engl J Med, 345, 159, 10.1056/NEJM200107193450301 Rebbeck, 2004, Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group, J Clin Oncol, 22, 1055, 10.1200/JCO.2004.04.188 Hartmann, 1999, Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer, N Engl J Med, 340, 77, 10.1056/NEJM199901143400201 Geiger, 2005, A population based study of bilateral prophylactic mastectomy in women at elevated risk of breast cancer in community practices, Arch Intern Med, 165, 516, 10.1001/archinte.165.5.516 Borgen, 1998, Patient regrets after bilateral prophylactic mastectomy, Ann Surg Oncol, 5, 603, 10.1007/BF02303829 Schrag, 1997, Decision analysis-effects of prophylactic mastectomy and oophrectomy on life expectancy among women with BRCA1 or BRCA2 mutations, N Engl J Med, 336, 1465, 10.1056/NEJM199705153362022 Grann, 2002, Effect of prevention studies on survival and quality-adjusted survival of women with BRCA 1/2 mutations: an updated decision analysis, J Clin Oncol, 20, 2520, 10.1200/JCO.2002.10.101 Frost, 2000, Long term satisfaction and psychological and social function following bilateral prophylactic mastectomy, JAMA, 284, 319, 10.1001/jama.284.3.319 Metcalfe, 2005, Predictors of quality of life in women with a bilateral prophylactic mastectomy, Breast J, 11, 65, 10.1111/j.1075-122X.2005.21546.x van Sprundel, 2005, Risk reduction of contralateral breast cancer and survival after contralateral mastectomy in BRCA1 and BRCA2 mutation carriers, Br J Cancer, 93, 287, 10.1038/sj.bjc.6602703 McDonnell, 2001, Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer, J Clin Oncol, 19, 3938, 10.1200/JCO.2001.19.19.3938 Peralta, 2000, Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer, Am J Surg, 180, 439, 10.1016/S0002-9610(00)00505-5 Lee, 1995, Arguments against routine contralateral mastectomy for invasive lobular breast cancer, Surgery, 118, 640, 10.1016/S0039-6060(05)80030-3 Montgomery, 1999, Issues of regret in women with contralateral prophylactic mastectomies, Ann Surg Oncol, 6, 546, 10.1007/s10434-999-0542-1 Geiger, 2006, Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy, J Clin Oncol, 24, 1350, 10.1200/JCO.2005.01.9901 Frost, 2005, Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance, J Clin Oncol, 23, 7849, 10.1200/JCO.2005.09.233 Kauff, 2002, Risk reducing salpingo-oophrectomy in women with BRCA1 or BRCA2 mutations, N Engl J Med, 346, 1609, 10.1056/NEJMoa020119 Rebbeck, 2002, Prophylactic oophrectomy in carriers of BRCA1 and BRCA2 mutations, N Engl J Med, 346, 1616, 10.1056/NEJMoa012158 Eisen, 2005, Breast cancer risk following bilateral prophylactic oophrectomy in carriers of BRCA1 and BRCA2 mutations: an international case control study, J Clin Oncol, 23, 7491, 10.1200/JCO.2004.00.7138 Fisher, 1998, Tamoxifen for prevention of breast cancer. Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371 Vogel, 2006, Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP study of tamoxifen and raloxifene (STAR) P-2 trial, JAMA, 295, 2727, 10.1001/jama.295.23.joc60074 Land, 2006, Patient-reported symptoms and quality of life during treatment with Tamoxifen or Raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial, JAMA, 295, 2742, 10.1001/jama.295.23.joc60075 Land, 2006, Quality-of-life valuations of advanced breast cancer by New Zealand women, Pharmacoeconomics, 24, 415, 10.2165/00019053-200624040-00010 MacMahon, 1970, Age at first birth and breast cancer risk, Bulletin of the World Health Organization, 43, 209 Russo, 2000, Hormonal approach to breast cancer prevention, J Clin Biochem Suppl, 34, 1, 10.1002/(SICI)1097-4644(2000)77:34+<1::AID-JCB2>3.0.CO;2-G Society of Surgical Oncology Nckhlyudov, 2005, Women's decision making roles regarding contralateral prophylactic mastectomy, J Natl Cancer Inst Monogr, 35, 55, 10.1093/jncimonographs/lgi038